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Background: Malaria in pregnancy is a major public health problem in endemic countries. Though the signs and
symptoms of malaria among pregnant women have been already described, clinical presentation may vary
according to intensity of transmission and local perceptions. Therefore, determining common signs and symptoms
among pregnant women with a malaria infection may be extremely useful to identify those in need of further
investigation by rapid diagnostic test or microscopy.
Methods: Six hundred pregnant women attending the maternity clinic of Nanoro District Hospital, Burkina Faso
were recruited, 200 with suspected clinical malaria and 400 as controls. Cases were matched with controls by
gestational age and parity. Signs and symptoms were collected and a blood sample taken for rapid diagnostic test,
microscopy and haemoglobin measurement. A multivariate model was used to assess the predictive value of signs
and symptoms for malaria infection.
Results: The overall prevalence of malaria was 42.6% (256/600) while anaemia was found in 60.8% (365/600) of
the women. Nearly half (49%) of the cases and 39.5% of the controls had a malaria infection (p = 0.03). The most
common signs and symptoms among the cases were fever (36%,72/200), history of fever (29%,58/200) and
headache (52%,104/200). The positive predictive value for fever was 53% (95% CI:41–64), history of fever 58%
(95% CI:37–63) and headache 51% (95% CI:41–61).
Conclusion: Signs and symptoms suggestive of malaria are frequent among pregnant women living in areas of
intense transmission. Common malaria symptoms are not strong predictors of infection. For a better management
of malaria in pregnancy, active screening to detect and treat malaria infection early should be performed on all
pregnant women attending a health facility.
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Malaria in pregnancy (MiP) is a major public health
problem in endemic countries where 31 million preg-
nancies occur annually, resulting in approximately 23
million live births [1]. Where malaria transmission is
moderate to high and stable, the most common parasite
species is Plasmodium falciparum and MiP is predom-
inantly asymptomatic and yet a major cause of maternal
anaemia and low birth weight (LBW), the latter increas-
ing the risk of infant death. Successful control of MiP
may prevent 75,000-200,000 infant deaths every year
[2]. In areas of low transmission, women by the time
they become pregnant have acquired little immunity to
malaria and so infections are often symptomatic and
more likely to become severe, resulting in maternal
and foetal deaths [2,3]. To prevent the consequences of
MiP, the World Health Organization (WHO) recom-
mends intermittent preventive treatment during preg-
nancy (IPTp), adequate management of clinical malaria,
administering of supplements such as iron and folic
acid, and the use of insecticide-treated nets [4].
The current strategy for clinical case management of
malaria in pregnant women is based on the result of rapid
diagnostic tests (RDT) or microscopy if available. Though
the signs and symptoms of malaria among pregnant
women have been already described in few settings, clin-
ical presentation may vary according to intensity of
transmission and local perceptions. Therefore, determin-
ing common signs and symptoms among pregnant
women with a malaria infection may be extremely useful
to identify those in need of further investigation by rapid
diagnostic test or microscopy [5-7]. Furthermore, there is
little information on the association between peripheral
parasitaemia and the presence of signs and symptoms
of malaria during pregnancy. This study aimed to docu-
ment the clinical presentation of malaria among pregnant
women and assess their predictive value.
Methods
Study area
The study was carried out at the Clinical Research Unit
of Nanoro (CRUN), situated in the centre of Burkina
Faso, 85 km from Ouagadougou, the capital city. Nanoro
district is one of the five districts of the Centre-West
health region. The main local language is Mooré, though
French is the official language. The literacy rate is low
for both men and women (about 23%) and there is a
high migration flux among the youngsters toward the
capital city and/or the border countries.
Malaria transmission is high with the entomological in-
oculation rate (EIR) in 2009 estimated at 50–60 infective
bites/person/year (Diabate, pers comm). The more com-
mon vectors are Anopheles gambiae sensu stricto, Anopheles
funestus and Anopheles arabiensis, and malaria is one of themost common reasons for attending a health facility [8].
Plasmodium falciparum is the predominant malaria para-
site. Malaria transmission is seasonal, during the months
of August-December, and overlaps with the rainy season
(July-October). The peak for malaria cases usually occurs in
September-October.
Since February 2009, the CRUN has implemented a
demographic surveillance system (DSS) involving about
54,000 individuals. Some important information such as
socio-economic status, e g, characteristics of households,
living conditions, health conditions, are collected through
the DSS on a regular basis.
The national anti-malarial drug policy was changed in
2005 from chloroquine to either amodiaquine-artesunate
(AQ-AS) or artemether-lumefantrine (AL) as first-line
treatments. Pregnant women received an insecticide-
treated net (ITN) free of charge as soon as they complete
two prenatal consultations or after delivery, while children
receive theirs at each vaccination campaign. Nevertheless,
a campaign for the promotion of insecticide-treated mate-
rials (ITM) targeting pregnant women and children under
five years has been implemented since 2010 and nowadays
an ITN is given to any pregnant woman attending for the
first time during pregnancy an health facility.
Study design and procedures
The study protocol was approved by the Institutional
Ethic Committee of Centre Muraz (registration no. 005-
2010/CE-CM). All pregnant women attending either the
routine antenatal care (ANC) or the outpatient clinic
were asked to participate in the study. During the visit
and after having obtained a written informed consent,
women were divided in cases or controls. Cases had
at least one of the following signs and symptoms:
temperature ≥37.5°C (measured by electronic thermo-
meter) or history of fever in the previous 48 hours,
headache, pallor, arthromyalgia, convulsions, vomiting,
dizziness, malaise, fatigue, enlarged liver or enlarged
spleen. Controls had none of them. For each case, two
controls, matched by parity (0, 1–3, ≥4), gestational age
(measured by fundal height) and seasonality (recruited
within one month from the corresponding case). In
order to capture possible seasonal variations in the clin-
ical presentation, the study was conducted during both
the low and high malaria transmission season.
Capillary blood was collected for an HRP-2 RDT, haemo-
globin and blood slide. Women with a positive RDT were
treated with AQ-AS (standard adult dose) if they were in
the second and third trimester of pregnancy while quinine
was given for seven days to those in the first trimester
(8 mg quinine base/kg every eight hours). Severe malaria
cases were hospitalized and treated with parenteral quin-
ine. Anaemia was treated according to the national guide-
lines with oral ferrous sulphate (200 mg) and folic acid
Table 1 Baseline characteristics of the recruited pregnant
women by study group (%)
Cases Controls Total
N = 200 N = 400 N = 600
Age group <20 years 18 (9.0) 23 (5.8) 41 (6.8)
20-34 years 160 (80.0) 328 (82.0) 488 (81.3)
≥35 years 22 (11.0) 49 (12.2) 71 (11.8)
Trimester ǂ 1st 10 (5.00 20 (5.0) 30 (5.0)
2nd 84 (42.0) 123 (30.8) 207 (34.5)
3rd 106 (53.00 257 (64.2) 363 (60.5)
Parity 0 17 (8.5) 34 (8.5) 51 (8.5)
1-3 118 (59.0) 237 (59.3) 355 (59.2)
≥4 65 (32.5) 129 (32.2) 194 (32.3)
Transmission seasonΦ No 47 (23.5) 8 (2.0) 55 (9.2)
Yes 153 (76.5) 392 (98.0) 545 (90.8)
Sleep under bed net 155 (77.5) 364 (91.0) 519 (86.5)
Malaria infection 98 (49.0) 158 (39.5) 256 (42. 7)
ǂ1st trimester: 0–12 weeks; 2nd trimester: 13–24 weeks; 3rd trimester: ≥25.
ΦTransmission season: August to December, no transmission season: June
to July.
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parasites and anaemia were promptly and adequately
treated free of charge. Project staff was available 24 hours a
day to identify women and to ensure adequate documenta-
tion and clinical management.
Laboratory methods
RDTs were carried out and results read according to the
manufacturer’s procedures. All slides were read twice by
two independent readers. Parasite density was estimated
by counting the number of asexual parasites per 200
leukocytes in the thick blood film and assuming white
blood cells (WBC) count of 8,000 parasites/μl. In case of
discrepancy between the two readers (positive/negative,
more than two-fold difference for parasite densities
≥400/μl, or more than the log10 for those <400/μl) [9], a
third independent reading was done. The latter was
taken as the final result. Haemoglobin was measured
using a portable spectrophotometer (Hemocue®, Angelholm,
Sweden) and controls were run daily to ensure the quality
of the results.
Sample size calculation
The sample size was calculated using the power calcula-
tion module for a two-sample comparison in order to
detect with a two-sided significance level of 5% and 90%
power important predictors of malaria infection in preg-
nant women. As there are no data available for the study
area, the estimation was based on a study conducted
in Mozambique [5]. It was assumed that 67% women
would report history of fever and that among them 33%
would be infected with malaria, while the prevalence of
infection among the other women would be 20%. Fol-
lowing these parameters, six hundred pregnant women
(200 cases and 400 controls) were needed. With an
expected malaria prevalence of 27%, ie, 162 infected
women, 16 possible predictors could be assessed, on the
assumption that each of them would need at least ten
events.
Statistical methods and definitions
Double data entry, validation and cleaning were done
using Epidata 3.1, and statistical analysis was performed
with STATA.10 (STATA Corporation, College Station,
TX, USA). Participants were categorized first as (i) cases
and (ii) controls. The frequencies of signs and symptoms
were compared between these groups. Odds ratio (OR)
estimates and their confidence intervals (CI) were esti-
mated in log binomial regression analyses. A P-value of
≤0.05 was considered statistically significant. The an-
aemia was classified as mild (Hb <11 g/dl), moderate
(Hb 7–9 g/dl) and severe (Hb <7 g/dl). Parasite density
was log transformed for the comparisons of mean para-
site densities between cases and controls.Results
Most recruited women were either in the second (34.5%,
207/600) or third (60.5%, 363/600) trimester of pregnancy,
and the mean age was 27.6 years (95% CI:27.1-28.0). More
than half of them had already had one to three pregnan-
cies and most of them were married (Table 1). The large
majority of them worked at home (99%, 593/600) and
could not read (92.1%, 553/600). Most women slept under
a bed net (86.5%%). Baseline characteristics were similar
between cases and controls (Table 1).
The prevalence of malaria infection using the RDT was
60% among the cases and 47.8% among the controls.
When using microscopy, the prevalence of malaria in-
fection was 49.0% among cases and 39.5% among controls
(p = 0.03). The latter would not have been treated in case
of clinical diagnosis. The mean (geometric) parasite dens-
ity among infected women was not significantly different
among cases (3.0/μl, 95% CI: 2.9-3.2) and controls (2.8/μl,
95% CI:2.7-3.0) (p = 0.06). This is clearly illustrated by the
Receiver Operating Characteristics (ROC) curve, with only
56% under the curve and no clear-cut off point distin-
guishing a case from a control (Figure 1). More than half
of infected women (56.3%, 144/256) had a parasite density
<1,000/μl. Malaria infection was strongly associated with
anaemia (OR:1.96, 95% CI:1.40-2.74; p < 0.01), with more
than half of all malaria-infected women (68.7%, 176/256)
being anaemic. Among symptomatic cases, age was signifi-
cantly related to malaria infection, with women <20 years
more at risk than those ≥35 years old (Table 2). Con-
versely, neither season gestational age or bed net use were
significantly associated with malaria, though there was the
Figure 1 ROC curve assessing the parasite density
discriminating a case from a control (case threshold).
Table 3 Positive predictive value (PPV) of clinical signs
and symptom for Plasmodium falciparum infection
among the 200 pregnant women recruited as cases
Signs/Symptoms n % PPV (%) (95%CI)
Fever 38 19.0 53 (41–64)
History of fever 29 14.5 58 (37–63)
Pain in the joints 6 3.0 25 (6 – 44)
Headache 57 28.5 51 (41 – 61)
Dizziness 3 1.5 47 (41–64)
Vomiting 3 1.5 38 (37–63)
Convulsions 1 0.5 33 (6–79)
Malaise 7 3.5 30 (41 –61)
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in multigravidae and before the transmission season
(Table 2).
Fever, history of fever, headache, and dizziness each
had a positive predictive value (PPV) around 50%, while
for all the others the PPV was well below (Table 3). The
highest PPV were found when combining fever and
dizziness (61.5%, 95%CI:35–82), and fever and vomiting
(66.7%, 95%CI:20–93). If fever had been used to diag-
nose malaria, 47.2% of the febrile women would have
been unnecessarily treated. Also 46.8% of the non-febrile
women would have missed treatment for their malaria
infection. When considering only fever as symptom, the
ROC curve was flat, indicating that no fever “threshold”
could be determined (Figure 2).
The occurrence of signs and symptoms was associated
with higher parasite densities; in women complaining of
headache, parasite density was significantly higher thanTable 2 Plasmodium falciparum infection by risk factors amon
Risk factors n/N
Age <20 years 11/1
20-34 years 79/1
≥35 years 8/26





Gestational age 1st 3/10
2nd 48/8
3rd 47/1
Bed net use Yes 20/5
No 76/1in those without (6.4/μl vs 1.8/μl)(p = 0.003). Moreover,
the mean (geometric) parasite density tended to be
higher in women with vomiting (14,617.8/μl vs 2.7/μl;
p = 0.05), fever (5.7/μl vs 2.2/μl) (p = 0.07), and com-
plaining of malaise (53.5 vs 2.7; p = 0.07).
In the univariate analysis, presence of symptoms (OR =
1.47, 95%CI:1.05-2.07; p = 0.03), fever (OR = 1.76, 95%
CI:0.99-3.11; p = 0.05) and headache (OR = 1.53, 95%
CI:0.96-2.46; p = 0.07) were or tended to be associated with
malaria infection. In the multivariate model, fever and his-
tory of fever (OR = 1.83, 95%CI:1.16-2.88; p = 0.009) also
fever and history of fever and headache infection (OR =
1.63, 95%CI:1.13-2.37; p = 0.01) were significantly associ-
ated with malaria infection (Table 4).
Discussion
In this study, malaria infection was extremely common
among pregnant women, regardless of signs and symp-
toms. Signs and symptoms were not discriminative for
malaria infections. In peripheral health facilities withoutg symptomatic pregnant women
(%) OR (95%CI) P-value
6 (69.0) Ref –
58 (50.0) 0.45 (0.15-1.37) 0.16
(31.0) 0.20 (0.05-0.78) 0.02
7 (34.0) Ref —
53 (53.0) 1.59 (0.88-2.86) 0.12
7 (59.0) Ref –
00 (50.0) 0.70 (0.25-1.95) 0.49
5 (45.0) 0.56 (0.19-1.66) 0.30
(30.0) Ref —
4 (57.1) 3.31 (0.75-12.86) 0.11
06 (44.3) 1.85 (0.45-7.58) 0.38
0 (40.0) Ref —
47(51.7) 1.60 (0.83-3.08) 0.15
Figure 2 ROC curve assessing the parasite density
discriminating women with or without fever (fever threshold).
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croscopy, health staff may have unnecessarily treated
half of the women with signs and symptoms suggestive
of malaria, while a substantial proportion of infected
pregnant women would have gone undetected. Assum-
ing diagnostic tests were available, the recommendation
of performing them only on suspected cases would haveTable 4 Comparison of the association between signs/sympto
women and their matched controls
n/N




History of fever No 39/
Yes 27/












Fever and No 84/
history of fever Yes 59/
Fever and No 131
history of fever and headache Yes 86/still missed several infected women. This is particularly
worrying for those in the first trimester of pregnancy as
they do not receive the sulphadoxine-pyrimethamine
(SP) for IPTp. Moreover, it has been repeatedly reported
that coverage of IPTp with at least two administered
doses of SP is still relatively low, despite women attend-
ing antenatal clinics several times during their preg-
nancy [10,11].
In endemic countries, assuming that any pregnant
woman attending an antenatal clinic is infected with
malaria, regardless of symptoms, seems to be the right
approach. This means that pregnant women should be
either systematically screened for malaria infection and
treated if positive or given SP at any time they visit a
health centre, provided this is done at least one month
apart. The latter has been recently recommended by the
WHO Malaria Policy Advisory Committee and Secretar-
iat [12] though it has not been implemented widely yet.
For women in the first trimester of pregnancy systematic
screening is probably the best approach as they cannot
be given SP as IPTp. Active detection of malaria infec-
tion among pregnant women can have a major impact
on miscarriage and pre-term delivery [13,14] and mater-
nal mortality. Indeed, at the north-western border ofms and malaria infection in symptomatic pregnant
(%) OR (95% CI) P value
/400 (40) Ref. —
200 (49) 1.47 (1.05-2.07) 0.03
144 (39) Ref. —
72 (53) 1.76 (0.99-3.11) 0.05
110 (35) Ref.
55 (49) 1.76 (0.91-3.39) 0.09
48 (29) 1.23 (0.40 - 3.76) 0.71
4 (25) ref —
208 (40) Ref.
104 (51) 1.53 (0.96-2.46) 0.08
76 (51) 1.17 (0.53-2.55) 0.69
38 (47) Ref —




48 (35) 1.33 (0.46-3.84) 0.60
4 (29) ref
230 (37) Ref.
115 (51) 1.83 (1.16, 2.88) 0.01
/340 (39) Ref.
170 (51) 1.63 (1.13, 2.37) 0.01
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cline in the overall maternal mortality ratio (MMR), with
P. falciparum malaria related MMR falling from an esti-
mated 1,000/100,000 live births prior to weekly screen-
ing to zero in 2005 [15].
The prevalence of malaria infection was significantly
higher in women with symptoms suggestive of malaria but
none of them or no combination of any of them had a very
high PPV. This is confirmed by the weak association be-
tween malaria infection and any of the signs and symptoms,
underlying the importance of parasitological diagnosis for
any suspected case. The parasite density in pregnancy is
not related to being a symptomatic patient and does not in-
crease the probability that fever is related to malaria.
In places where transmission is high, malaria infection
during pregnancy is often asymptomatic [16,17]. In
Mozambique, signs and symptoms suggestive of malaria
were extremely common in pregnant women but malaria
infection was confirmed in only a minority of them [5].
The large majority of infections detected in pregnant
women was asymptomatic in Benin [6]. Nevertheless, in
Ghana malaria-infected pregnant women were often
symptomatic, with history of fever, headache, vomiting,
malaise, and dizziness occurring significantly more fre-
quently than in uninfected women [7]. This is surprising
when considering that the study was carried out in an
area of stable and intense transmission. Indeed, in most
of the previous reports from areas of intense transmis-
sion, malaria infection in pregnancy was often asymp-
tomatic and this is also confirmed by this study. All
common signs and symptoms, taken alone or in com-
bination, had low PPV, with the only exception of two
combinations, ie, fever and dizziness, and fever and
vomiting. Nevertheless, even though the PPV for these
two combinations was above 60%, about 30-40% of
women with these complaints would have been unneces-
sarily treated for malaria. Pregnant women displaying
signs and symptoms suggestive of malaria but without
confirmed malaria should also be screened for others in-
fectious diseases.
Several known risk factors such as maternal age [18,19]
and parity [20] were confirmed to be associated with mal-
aria infection during pregnancy, although in some in-
stances the difference was not statistically significant,
probably due to the need for a larger sample size. In
addition, the risk of malaria infection did not vary signifi-
cantly by gestational age, though the prevalence was the
highest in the second trimester, an observation reported in
other studies in which the peak prevalence during preg-
nancy was at 13–16 weeks of gestation [21,22].
Conclusion
Malaria-related signs and symptoms, e.g. fever or head-
ache, although more frequent in pregnant women with amalaria infection, cannot be used to identify those in
need of treatment as a large proportion of asymptomatic
women can be infected. Any pregnant women attending
a health facility should be tested regardless of symptoms
for malaria infection, either by microscopy or RDT. This
would be particularly useful for women in the first tri-
mester of pregnancy as they cannot be administered SP
as IPTp.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
The study was conceived by UDA and this paper drafted by MCT and UDA.
It was conducted by MCT and HT with substantial contributions from JM.
Data analyses were conducted by MCT, and supervised by AE and JM. AE,
JBO, RTG, JPVG, HT and UDA participated in the overall running of the study,
contributed to the interpretation of data, and gave critical review of the final
draft. All authors read and approved the final version.
Acknowledgements
We are grateful to all the women who participated in this study. We thank
the entire medical laboratory and administrative staff of the Clinical Research
Unit of Nanoro, the medical staff at the CSPSs of Nanoro and Nazoanga for
their valuable contribution. We would particularly like to thank Dr Sabine
Gies for her advice and comments, Dr Kabore William for his commitment to
the implementation of the study in the field, Dr Valea Innocent and Dr
Sorgho Hermann for their useful advice; Ouedraogo Sayouba and Kazienga
Adama for the double entry and cleaning of the data and Lompo
Palpouguini for coordinating the slide reading.
Author details
1Institut de Recherche en Sciences de la Santé/Direction Régionale de
l’Ouest, 01 BP 545 Bobo-Dioulasso, Burkina Faso. 2Laboratory of Parasitology
and Entomology, Centre Muraz, Bobo Dioulasso, 01 BP 390 Bobo-Dioulasso,
Burkina Faso. 3Department of Public Health, Institute of Tropical Medicine,
Nationalstraat155, B-2000 Antwerpen, Belgium. 4International Health Unit,
University of Antwerp, Antwerp, Belgium. 5Disease Control and Elimination
Theme, Medical Research Council Unit, Fajara, The Gambia.
Received: 20 August 2013 Accepted: 19 December 2013
Published: 27 December 2013
References
1. Dellicour S, Tatem AJ, Guerra CA, Snow RW, ter Kuile FO: Quantifying the
number of pregnancies at risk of malaria in 2007: a demographic study.
PLoS Med 2010, 7:1.
2. Rodriguez-Morales AJ, Sanchez E, Vargas M, Piccolo C, Colina R, Arria M,
Franco-Paredes C: Pregnancy outcomes associated with Plasmodium vivax
malaria in Northeastern Venezuela. Am J Trop Med Hyg 2006, 74:755–757.
3. Singh N, Mehra RK, Srivastava N: Malaria during pregnancy and infancy, in
an area of intense malaria transmission in central India. Ann Trop Med
Parasitol 2001, 95:15–29.
4. WHO/AFRO: A strategic framework for malaria prevention and control during
pregnancy in the African region. 2004. AFR/MAL/04/01.
5. Bardaji A, Sigauque B, Bruni L, Romagosa C, Sanz S, Mabunda S,
Mandomando I, Aponte J, Sevene E, Alonso PL, Menendez C: Clinical
malaria in African pregnant women. Malar J 2008, 7:27.
6. Huynh BT, Fievet N, Gbaguidi G, Borgella S, Mevo BG, Massougbodji A,
Deloron P, Cot M: Malaria associated symptoms in pregnant women
followed-up in Benin. Malar J 2011, 10:72.
7. Tagbor H, Bruce J, Browne E, Greenwood B, Chandramohan D: Malaria in
pregnancy in an area of stable and intense transmission: is it
asymptomatic? Trop Med Int Health 2008, 13:1016–1021.
8. Ministère de la Santé (Burkina Faso): Statistiques sanitaires. Ouagadougou; 1994.
9. Greenwood BM, Armstrong JRM: Comparison of two simple methods
fordetermining malaria parasite density. Trans R Soc Trop Med Hyg 1991,
85:186–188.
Tahita et al. Malaria Journal 2013, 12:464 Page 7 of 7
http://www.malariajournal.com/content/12/1/46410. Koen P, Gies S, Coulibaly SO, Ky C, Somda J, Toomer E, Ribera JM,
D’Alessandro U: Bottlenecks for High coverage of intermittent preventive
treatment in pregnancy: the case of adolescent pregnancies in rural
Burkina Faso. PLoS One 2010, 5:8.
11. Chima AO, Kara H, Obinna EO: Low coverage of intermittent preventive
treatment for malaria in pregnancy in Nigeria:demand-side influences.
Malar J 2012, 11:82.
12. World Health Organization: Malaria Policy Advisory Committee and
Secretariat Malaria Policy Advisory Committee to the WHO:conclusions
and recommendations of September 2012 meeting. Malar J 2012, 11:424.
13. Bardaji A, Sigauque B, Sanz S, Maixenchs M, Ordi J, Aponte JJ, Mabunda S,
Alonso PL, Menendez C: Impact of malaria at the end of pregnancy on
infant mortality and morbidity. J Infect Dis 2011, 203:691–699.
14. Luxemburger C, McGready R, Kham A, Morison L, Cho T,
Chongsuphajaisiddhi T, White NJ, Nosten F: Effects of malaria during
pregnancy on infant mortality in an area of low malaria transmission.
Am J Epidemiol 2001, 154:459–465.
15. McGready R, Boel M, Rijken MJ, Ashley EA, Cho T, Moo O, Paw MK,
Pimanpanarak M, Hkirijareon L, Carrara VI, Lwin KM, Phyo AP, Turner C, Chu
CS, van Vugt M, Price RN, Luxemburger C, ter Kuile FO, Tan SO, Proux S,
Singhasivanon P, White NJ, Nosten FH: Effect of early detection and
treatment on malaria related maternal mortality on the north-western
border of Thailand 1986–2010. PLoS One 2012, 7:7.
16. Desai M, ter Kuile FO, Nosten F, McGready R, Asamoa K, Brabin B, Newman
RD: Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis
2007, 7:93–104.
17. Nosten F, Rogerson SJ, Beeson JG, McGready R, Mutabingwa TK, Brabin B:
Malaria in pregnancy and the endemicity spectrum: what can we learn?
Trends Parasitol 2004, 20:425–432.
18. Rogerson SJ, van den Broek NR, Chaluluka E, Qongwane C, Mhango CG,
Molyneux ME: Malaria and anemia in antenatal women in Blantyre,
Malawi: a twelve-month survey. Am J Trop Med Hyg 2000, 62:335–340.
19. Dicko A, Mantel C, Aly Thera M, Doumbia S, Diallo M, Diakete M, Sagara I,
Doumbo O: Risk factors for malaria infection and anemia for
pregnantwomen in the Sahel area of Bandiagara, Mali. Afr J Med Med Sci
2003, 89:17–23.
20. Kyabayinze DJ, Tibenderana JK, Nassali M, Tumwine LK, Riches C, Montague
M, Counihan H, Hamade P, Van Geertruyden JP, Meek S: Placental
Plasmodium falciparum malaria infection: operational accuracy of HRP2
rapid diagnostic tests in a malaria endemic setting. Malar J 2011, 10:306.
21. Brabin BJ: An analysis of malaria in pregnancy in Africa. Bull World Health
Organ 1983, 61:1005–1016.
22. Diagne N, Rogier C, Sokhna CS, Tall A, Fontenille D, Roussilhon C, Spiegel A,
Trape JF: Increased susceptibility to malaria during the early postpartum
period. New Microbiol 2000, 343:598–603.
doi:10.1186/1475-2875-12-464
Cite this article as: Tahita et al.: Clinical signs and symptoms cannot
reliably predict Plasmodium falciparum malaria infection in pregnant
women living in an area of high seasonal transmission. Malaria Journal
2013 12:464.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
